Skip to main content
Erschienen in: Rheumatology International 3/2015

01.03.2015 | Original Article

Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region

verfasst von: Tarek Carlos Salman-Monte, Vicenç Torrente-Segarra, Juan Muñoz-Ortego, Sergi Mojal, Jordi Carbonell-Abelló

Erschienen in: Rheumatology International | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Studies have found an increase in bone loss and fracture in individuals with systemic lupus erythematosus (SLE) compared with general population. The aim of this study was to describe the prevalence of osteopenia, osteoporosis, and fragility fractures and to find potential predictors of bone loss in our cohort of SLE patients. We performed a cross-sectional study and collected 67 bone density measurements (BMD) of our SLE patients. We also collected sociodemographic data, 25-OH-vitamin D levels, serological markers, activity index, SLE cumulative damage index, and pharmacologic treatment. Sixty-seven consecutive BMD from SLE patients were assessed. Osteopenia was found in 28–46 % of SLE patients. Osteoporosis ranged from 3 to 9 %. The only statistically significant correlation we found was between weight and height with total hip and femoral neck BMD (p < 0.05). The most frequent BMD-affected site was at the femoral neck, showing osteopenia in 46.2 % of SLE patients. Osteoporosis was found in up to 8.9 % of SLE patients. We found no predictors of bone loss in relation to the disease activity or its treatment. Fragility fractures were seen in 4.4 % of SLE patients. All patients with fragility fractures showed osteopenia at BMD. There is a high prevalence of bone loss in SLE patients, since up to 46 % of SLE patients showed low BMD. Total hip and femoral neck osteopenia were the most frequent findings correlated with low BMI. We found a lower prevalence of fragility fractures compared with other series.
Literatur
1.
Zurück zum Zitat Alele JD, Kamen DL, Hunt KJ, Ramsey-Goldman R (2011) Bone geometry profiles in women with and without SLE. J Bone Miner Res 26:2719–2726CrossRefPubMed Alele JD, Kamen DL, Hunt KJ, Ramsey-Goldman R (2011) Bone geometry profiles in women with and without SLE. J Bone Miner Res 26:2719–2726CrossRefPubMed
2.
3.
Zurück zum Zitat Yee CS, Crabtree N, Skan J et al (2005) Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 64:111–114CrossRefPubMedCentralPubMed Yee CS, Crabtree N, Skan J et al (2005) Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 64:111–114CrossRefPubMedCentralPubMed
4.
Zurück zum Zitat Jacobs J, Korswagen LA, Schilder AM et al (2013) Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int 24:1827–1833CrossRefPubMed Jacobs J, Korswagen LA, Schilder AM et al (2013) Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int 24:1827–1833CrossRefPubMed
5.
Zurück zum Zitat Dhillon VB, Davies MC, Hall ML et al (1990) Assessment of the effects of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy X-ray absorptiometry. Ann Rheum Dis 149:624–626CrossRef Dhillon VB, Davies MC, Hall ML et al (1990) Assessment of the effects of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy X-ray absorptiometry. Ann Rheum Dis 149:624–626CrossRef
6.
Zurück zum Zitat Almehed K, Forsblad d’Elia H, Kvist G, Ohlsson C, Carlsten H (2007) Prevalence and risk factors of osteoporosis in female SLE patients-extended report. Rheumatology (Oxford) 46:1185–1190CrossRef Almehed K, Forsblad d’Elia H, Kvist G, Ohlsson C, Carlsten H (2007) Prevalence and risk factors of osteoporosis in female SLE patients-extended report. Rheumatology (Oxford) 46:1185–1190CrossRef
7.
Zurück zum Zitat Yeap SS, Othman AZ, Zain AA, Chan SP (2012) Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids. Int J Rheum Dis 15:17–24CrossRefPubMed Yeap SS, Othman AZ, Zain AA, Chan SP (2012) Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids. Int J Rheum Dis 15:17–24CrossRefPubMed
8.
Zurück zum Zitat Becker A, Fischer R, Scherbaum WA, Schneider M (2001) Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage. Lupus 10:809–814CrossRefPubMed Becker A, Fischer R, Scherbaum WA, Schneider M (2001) Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage. Lupus 10:809–814CrossRefPubMed
9.
Zurück zum Zitat Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed
10.
Zurück zum Zitat Zhang FZ, Su MH, Li P (2012) Bone mineral density and disease activity in untreated systemic lupus erythematosus patients. Zhonghua Yi Xue Za Zhi 92:2331–2334PubMed Zhang FZ, Su MH, Li P (2012) Bone mineral density and disease activity in untreated systemic lupus erythematosus patients. Zhonghua Yi Xue Za Zhi 92:2331–2334PubMed
11.
Zurück zum Zitat Ward MM, Marx AS, Barry NN (2000) Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 27:664–670PubMed Ward MM, Marx AS, Barry NN (2000) Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 27:664–670PubMed
12.
Zurück zum Zitat Gladman DD, Goldsmith CH, Urowitz MB et al (2000) The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 27:373–376PubMed Gladman DD, Goldsmith CH, Urowitz MB et al (2000) The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 27:373–376PubMed
13.
Zurück zum Zitat Milligan SE, Hom DL, Ballou SP et al (1993) An assessment of the Health Assessment Questionnaire functional ability index among women with systemic lupus erythematosus. J Rheumatol 20:972–976PubMed Milligan SE, Hom DL, Ballou SP et al (1993) An assessment of the Health Assessment Questionnaire functional ability index among women with systemic lupus erythematosus. J Rheumatol 20:972–976PubMed
14.
Zurück zum Zitat Edworthy SM (2005) Clinical manifestations of systemic lupus erythematosus. In: Harris ED, Budd RC, Firestein GS (eds) Kelley’s textbook of rheumatology. Elsevier Saunders, US, pp 1201–1224 Edworthy SM (2005) Clinical manifestations of systemic lupus erythematosus. In: Harris ED, Budd RC, Firestein GS (eds) Kelley’s textbook of rheumatology. Elsevier Saunders, US, pp 1201–1224
15.
Zurück zum Zitat Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E (1997) Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 24:1922–1929PubMed Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E (1997) Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 24:1922–1929PubMed
16.
17.
Zurück zum Zitat Méndez JP, Rojano-Mejía D, Pedraza J et al (2012) Bone mineral density in postmenopausal Mexican-Mestizo women with normal body mass index, overweight, or obesity. Menopause 20:568–572 Méndez JP, Rojano-Mejía D, Pedraza J et al (2012) Bone mineral density in postmenopausal Mexican-Mestizo women with normal body mass index, overweight, or obesity. Menopause 20:568–572
18.
Zurück zum Zitat Mok CC, Ying SK, To CH, Ma KM (2008) Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study. Bone 43:327–331CrossRefPubMed Mok CC, Ying SK, To CH, Ma KM (2008) Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study. Bone 43:327–331CrossRefPubMed
19.
Zurück zum Zitat Muñoz-Ortego J, Torrente-Segarra V, Prieto-Alhambra D, Salman-Monte TC, Carbonell-Abello J (2012) Prevalence and predictors of vitamin D deficiency in non-supplemented women with systemic lupus erythematosus in the Mediterranean region: a cohort study. Scand J Rheumatol 41:472–475CrossRefPubMed Muñoz-Ortego J, Torrente-Segarra V, Prieto-Alhambra D, Salman-Monte TC, Carbonell-Abello J (2012) Prevalence and predictors of vitamin D deficiency in non-supplemented women with systemic lupus erythematosus in the Mediterranean region: a cohort study. Scand J Rheumatol 41:472–475CrossRefPubMed
20.
Zurück zum Zitat Li EK, Tam LS, Griffith JF et al (2009) High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 36:1646–1652CrossRefPubMed Li EK, Tam LS, Griffith JF et al (2009) High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 36:1646–1652CrossRefPubMed
21.
Zurück zum Zitat Steinbuch M, Youket TE, Cohens S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 15:323–328CrossRefPubMed Steinbuch M, Youket TE, Cohens S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 15:323–328CrossRefPubMed
22.
Zurück zum Zitat Lee C, Almagor O, Dunlop DD et al (2006) Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology (Oxford) 45:53–60CrossRef Lee C, Almagor O, Dunlop DD et al (2006) Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology (Oxford) 45:53–60CrossRef
23.
Zurück zum Zitat Teichmann J, Lange U, Stracke H, Federlin K, Bretzel RG (1999) Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatol Int 18:137–140CrossRefPubMed Teichmann J, Lange U, Stracke H, Federlin K, Bretzel RG (1999) Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatol Int 18:137–140CrossRefPubMed
Metadaten
Titel
Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region
verfasst von
Tarek Carlos Salman-Monte
Vicenç Torrente-Segarra
Juan Muñoz-Ortego
Sergi Mojal
Jordi Carbonell-Abelló
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 3/2015
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3087-y

Weitere Artikel der Ausgabe 3/2015

Rheumatology International 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Eingreifen von Umstehenden rettet vor Erstickungstod!

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.